<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01578226</url>
  </required_header>
  <id_info>
    <org_study_id>PCTCIRR</org_study_id>
    <nct_id>NCT01578226</nct_id>
  </id_info>
  <brief_title>Procalcitonin in Cirrhotic Patients at High Risk for Sepsis</brief_title>
  <official_title>Role of Procalcitonin (PCT) for the Diagnosis of Sepsis in Ascitic Cirrhotic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Prof. Facchinetti Fabio</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Modena and Reggio Emilia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Infections are frequent life-threatening events in patients with cirrhosis, occurring at
      least in 35% of hospitalized patients and accounting for 20% of inpatients death. Among
      cirrhotics, ascitic patients have the highest risk of death for sepsis. At the admission, no
      clear-cut clinical and biochemical features are helpful in diagnosing and prognostically
      stratifying those patients with sepsis. Procalcitonin (PCT)is a breakthrough marker
      presenting high sensibility and specificity in diagnosing bacterial infections in different
      clinical settings. The purpose of this study is to evaluate PCT as a diagnostic and
      prognostic tool for sepsis in hospitalized cirrhotic patients with ascitic decompensation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">September 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">75</enrollment>
  <condition>Cirrhosis</condition>
  <condition>Ascites</condition>
  <condition>Sepsis</condition>
  <arm_group>
    <arm_group_label>Decompensated cirrhotic patients</arm_group_label>
    <description>Cirrhotic patients presenting with clinically detectable ascites (Grade 2 o Grade 3)</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All ascitic cirrhotic patients admitted to our third level Liver Unit.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  liver cirrhosis regardless of aetiology

          -  clinically relevant ascitic decompensation at time of hospital admission

        Exclusion Criteria:

          -  high haematic ascites

          -  ongoing antimicrobial therapy or stopped less than 7 days before admission

          -  last hospital discharge within 7 days

          -  surgery or trauma within 30 days from enrolment

          -  hepatocellular carcinoma out of Milan criteria

          -  extra hepatic malignancies

          -  immunodeficiency syndrome

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Filippo Schepis, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Modena and Reggio Emilia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Gastroenterology Unit - University Hospital of Modena</name>
      <address>
        <city>Modena</city>
        <zip>41124</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>April 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 13, 2012</study_first_submitted>
  <study_first_submitted_qc>April 13, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 16, 2012</study_first_posted>
  <last_update_submitted>April 13, 2012</last_update_submitted>
  <last_update_submitted_qc>April 13, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 16, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Modena and Reggio Emilia</investigator_affiliation>
    <investigator_full_name>Prof. Facchinetti Fabio</investigator_full_name>
    <investigator_title>PRS Admin</investigator_title>
  </responsible_party>
  <keyword>Cirrhosis</keyword>
  <keyword>Ascites</keyword>
  <keyword>Decompensation</keyword>
  <keyword>Bacterial infection</keyword>
  <keyword>Sepsis</keyword>
  <keyword>Procalcitonin</keyword>
  <keyword>PCT</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Ascites</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcitonin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

